BSD Medical teams up with GE in MRI pact
This article was originally published in Clinica
Executive Summary
BSD Medical is set to integrate its BSD-2000/3D/MR cancer treatment system into an unspecified MRI technology developed by GE Medical Systems. The new integrated system will be installed at Duke University in Durham, Carolina. The technology will be designed to provide MRI monitoring of cancer treatments delivered by BSD’s systems. According to BSD (Salt Lake City, Utah), the BSD-2000 system can be used to monitor deep thermal therapy cancer treatments with thermal imaging via MR-tomography techniques. Financial details of the partnership were not revealed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals